Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Dosage Regimen: Overview01:15

Drug Dosage Regimen: Overview

4.1K
A drug dosage regimen describes the specific instructions and schedule for administering a drug to a patient. It considers factors such as drug dosage, frequency, route of administration, and duration of treatment. Designing an appropriate dosage regimen for a patient aims to achieve a target drug concentration at the site of action.
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
4.1K
Dosage Regimen: Fixed Dose01:01

Dosage Regimen: Fixed Dose

2.1K
Fixed-dose regimens are a common approach to administer drugs to achieve and maintain desired levels of the drug in the body. In this dosing strategy, a specific amount of medication is given at regular intervals, often multiple times a day, to ensure a consistent drug concentration in the bloodstream.
Fixed-dose regimens can be used for various routes of administration, including intravenous (IV) injections and oral medications. For IV administration, a predetermined amount of the drug is...
2.1K
Vaccinations01:51

Vaccinations

49.2K
Overview
49.2K
Bioavailability Study Design: Single Versus Multiple Dose Studies01:11

Bioavailability Study Design: Single Versus Multiple Dose Studies

80
Bioavailability studies are essential for understanding how a drug is absorbed, distributed, metabolized, and excreted in the body. These studies assess the extent and rate at which the active pharmaceutical agent becomes available at the site of action. The design of bioavailability studies can involve single-dose or multiple-dose regimens, each with distinct advantages and limitations.Single-dose studies are the preferred approach due to their simplicity and reduced drug exposure for...
80
Dosage Regimens: Designs and Approaches01:28

Dosage Regimens: Designs and Approaches

118
Designing a dosage regimen, which refers to the manner of drug administration, is a complex process involving the selection of drug dose, route, and frequency. This process is underpinned by pharmacokinetic parameters derived from tests and population averages. These parameters are then tailored to patient-specific variables such as diagnosis, demographics, and allergy status. Once therapy commences, therapeutic response monitoring is critical and achieved through clinical and physical...
118
Dosage Interval and Administration Route: Determination Methods01:19

Dosage Interval and Administration Route: Determination Methods

83
A medication’s effectiveness largely depends on its appropriate dosage and the route of administration. Dosage ensures that a sufficient drug concentration is maintained in the bloodstream to elicit the desired therapeutic effect without causing toxicity. The route of administration affects the drug's bioavailability, rate of absorption, and onset of action, which are crucial for achieving optimal therapeutic outcomes. Drug dosage calculations are critical to tailoring therapy to...
83

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Licensure Framework for Autonomous Clinical AI.

JAMA·2026
Same author

How AI will redefine care delivery: the rise of the generalist-specialist.

Health affairs scholar·2026
Same author

The Market Dynamics for Third-Party AI Tools Trying to Compete With Electronic Health Record Developers.

JAMA·2026
Same author

Measuring the Return on Investment for Clinician-Facing Artificial Intelligence Technologies.

JAMA internal medicine·2026
Same author

Asymptomatic Influenza A(H5N1) Infections and Sustained Surveillance-Sustaining Surveillance Beyond the Crisis.

JAMA network open·2025
Same author

National research ecosystems: protecting populations and building health security worldwide.

The Lancet. Global health·2025

Related Experiment Video

Updated: Nov 17, 2025

Dynamic Monitoring of Seroconversion using a Multianalyte Immunobead Assay for Covid-19
08:48

Dynamic Monitoring of Seroconversion using a Multianalyte Immunobead Assay for Covid-19

Published on: February 16, 2022

3.2K

Delayed Second Dose versus Standard Regimen for Covid-19 Vaccination

Siri R Kadire, Robert M Wachter, Nicole Lurie

    The New England Journal of Medicine
    |February 17, 2021
    PubMed
    Summary

    No abstract available in PubMed .

    More Related Videos

    Author Spotlight: Advancing Immune Monitoring in Critical Care Patients Using Whole Blood Assays
    06:03

    Author Spotlight: Advancing Immune Monitoring in Critical Care Patients Using Whole Blood Assays

    Published on: September 20, 2024

    1.6K
    Trans-vivo Delayed Type Hypersensitivity Assay for Antigen Specific Regulation
    11:49

    Trans-vivo Delayed Type Hypersensitivity Assay for Antigen Specific Regulation

    Published on: May 2, 2013

    16.4K

    Related Experiment Videos

    Last Updated: Nov 17, 2025

    Dynamic Monitoring of Seroconversion using a Multianalyte Immunobead Assay for Covid-19
    08:48

    Dynamic Monitoring of Seroconversion using a Multianalyte Immunobead Assay for Covid-19

    Published on: February 16, 2022

    3.2K
    Author Spotlight: Advancing Immune Monitoring in Critical Care Patients Using Whole Blood Assays
    06:03

    Author Spotlight: Advancing Immune Monitoring in Critical Care Patients Using Whole Blood Assays

    Published on: September 20, 2024

    1.6K
    Trans-vivo Delayed Type Hypersensitivity Assay for Antigen Specific Regulation
    11:49

    Trans-vivo Delayed Type Hypersensitivity Assay for Antigen Specific Regulation

    Published on: May 2, 2013

    16.4K